2 November 2018 |
CME Group completes acquisition of NEX |
2 November 2018 |
Scheme of arrangement becomes effective |
1 November 2018 |
Court sanction announcement |
31 October 2018 |
CMA clearance press release |
31 October 2018 |
CMA approval and timetable update |
12 October 2018 |
DOJ clearance press release |
12 October 2018 |
DOJ clearance and offer update |
26 June 2018 |
Second-quarter 2018 Financial Results Press Release |
26 June 2018 |
Half-year Report Announcement |
21 June 2018 |
Senior Notes Closing Announcement |
15 June 2018 |
Prospectus Supplement |
14 June 2018 |
Senior Notes Pricing Term Sheet |
14 June 2018 |
Senior Notes Pricing Announcement |
14 June 2018 |
Preliminary Prospectus Supplement |
14 June 2018 |
Roadshow Presentation |
14 June 2018 |
Senior Notes Offering Launch Announcement |
18 May 2018 |
Results of Court Meeting and General Meeting |
25 April 2018 |
Publication of Scheme Document announcement |
25 April 2018 |
Scheme Document dated 25 April 2018 |
25 April 2018 |
Forms of Proxy for Court Meeting and General Meeting |
25 April 2018 |
NEX Memorandum and Articles of Association |
25 April 2018 |
Proposed amendments to NEX Articles of Association |
25 April 2018 |
Fourth Amended and Restated Certificate of Incorporation of CME Group Inc. |
25 April 2018 |
Fourteenth Amended and Restated Bylaws of CME Group Inc. |
25 April 2018 |
Consent Letter from Citigroup Global Markets Limited in relation to the Scheme Document |
25 April 2018 |
Consent Letter from Evercore Group LLC in relation to the Scheme Document |
25 April 2018 |
Consent Letter from Evercore International LLP in relation to the Scheme Document |
25 April 2018 |
JPM Confirmation Letter |
25 April 2018 |
JPM Consent Letter |
25 April 2018 |
Barclays Consent and Confirmation Letter |
25 April 2018 |
Barclays Scheme Consent Letter |
25 April 2018 |
KPMG Confirmation Letter |
25 April 2018 |
CME's Form 10-K – 2017 |
25 April 2018 |
CME's Form 10-K – 2016 |
25 April 2018 |
NEX Annual Report and Accounts for financial year ended 31 March 2017 |
25 April 2018 |
NEX Annual Report and Accounts for financial year ended 31 March 2016 |
25 April 2018 |
NEX 2017 Half-Yearly Financial Report for period ended 30 September 2017 |
25 April 2018 |
NEX Q3 Trading Statement for period ended 31 December 2017 |
25 April 2018 |
Unaggregated dealings of Barclays Capital Inc and Barclays Capital Derivatives Funding LLC |
25 April 2018 |
Unaggregated dealings of Goldman, Sachs & Co .. LLC and Goldman Sachs Financial Markets, LP. |
29 March 2018 |
CME Group to Acquire NEX Group – Press Release |
29 March 2018
|
CME Group Analyst / Investor Call slide presentation
|
29 March 2018
|
Acquisition factsheet
|
29 March 2018 |
Offer for NEX Group plc — Rule 2.7 Announcement |
29 March 2018
|
Co-operation Agreement dated 29 March 2018
|
29 March 2018
|
364-Day Bridge Credit Agreement dated 29 March 2018
|
29 March 2018
|
Irrevocable Undertaking from Charles Gregson dated 28 March 2018
|
29 March 2018
|
Irrevocable Undertaking from Michael Spencer dated 28 March 2018
|
29 March 2018
|
Irrevocable Undertaking from Samantha Wren dated 28 March 2018
|
29 March 2018
|
Irrevocable Undertaking from John Sievwright dated 28 March 2018
|
29 March 2018
|
Irrevocable Undertaking from Ivan Ritossa dated 28 March 2018
|
29 March 2018
|
Irrevocable Undertaking from Robert Standing dated 28 March 2018
|
29 March 2018
|
Irrevocable Undertaking from Ken Pigaga dated 28 March 2018
|
29 March 2018
|
Irrevocable Undertaking from Anna Ewing dated 28 March 2018
|
29 March 2018
|
Confidentiality Agreement dated 15 February 2018
|
29 March 2018
|
Clean Team Confidentiality Agreement dated 20 February 2018
|
29 March 2018
|
Confidentiality and Joint Defense Agreement dated 13 March 2018
|
27 March 2018 |
Public Opening Position Disclosure by a Party to an Offer |
16 March 2018 |
Announcement regarding possible offer for NEX Group plc |